Advertisement
Screener

MANNKIND CORP (MNKD) Graph

MNKD Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $109.37M; Cost of revenue $14.41M; Selling, general and administrative $58.30M; Operating expenses $29.54M.
  • 2026-03-31: Revenue $90.17M; Cost of revenue $7.51M; Selling, general and administrative $54.09M; Operating expenses (m).
  • 2025-12-31: Revenue $111.95M*; Cost of revenue $13.93M*; Selling, general and administrative $58.41M*; Operating expenses (m).
  • 2025-09-30: Revenue $82.13M; Cost of revenue $4.50M; Selling, general and administrative $29.09M; Operating expenses (m).

Counterparty Name

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

MNKD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Cipla Ltd$0.00Revenue$109.37MCost of revenue$14.41MOperating expenses$29.54MOperating income-$350.00KOther income, net-$4.99MSelling, general& administrative$58.30MPre-tax income-$19.14MNet income-$19.03M

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

MNKD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.License And Service$35.02MProduct$41.98MRoyalty$32.37MService$5.42MProduct Revenue$71.58MRevenue$109.37MCost of revenue$14.41MOperating expenses$29.54MOperating income-$350.00KOther income, net-$4.99MSelling, general& administrative$58.30MPre-tax income-$19.14MNet income-$19.03M

Related Party Transactions By Related Party

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

MNKD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.UTCSA$29.60MUnited TherapeuticsCorporation$66.89MRevenue$109.37MCost of revenue$14.41MOperating expenses$29.54MOperating income-$350.00KOther income, net-$4.99MSelling, general& administrative$58.30MPre-tax income-$19.14MNet income-$19.03M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

MNKD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.All Other Segments$109.37MRevenue$109.37MCost of revenue$14.41MOperating expenses$29.54MOperating income-$350.00KOther income, net-$4.99MSelling, general& administrative$58.30MPre-tax income-$19.14MNet income-$19.03M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$109.37M$14.41M$58.30M$29.54M-$106.00K-$19.03M
2026-03-31$90.17M$7.51M$54.09M(m)$253.00K-$16.62M
2025-12-31$111.95M*$13.93M*$58.41M*(m)-$4.98M*-$15.95M*
2025-09-30$82.13M$4.50M$29.09M(m)-$204.00K$7.99M
2025-06-30$76.53M$4.61M$31.62M$20.57M$272.00K$668.00K
2025-03-31$78.35M$3.77M$25.01M(m)$459.00K$13.16M
2024-09-30$70.08M$3.20M$23.92M$18.02M$1.32M$11.55M
2024-06-30$72.39M$5.61M$24.11M$20.38M$323.00K-$2.01M
2024-03-31$66.26M$3.82M$22.33M$18.60M$264.00K$10.63M
2023-09-30$51.25M$4.00M(m)$14.25M$0.00$1.72M
2023-06-30$48.61M$5.22M(m)$14.24M$0.00-$5.26M
2023-03-31$40.63M$5.53M(m)$16.21M$0.00-$9.79M
2022-09-30$32.83M$5.02M$22.64M$17.46M$0.00-$14.43M
2022-06-30$18.89M$4.62M$26.04M$12.91M$0.00-$29.02M
2022-03-31$11.99M$2.28M$20.70M$11.00M$0.00-$26.00M
2021-09-30$22.21M$3.81M$17.22M$9.89M(m)-$4.43M
2021-06-30$23.28M$4.41M$20.06M$9.93M(m)-$35.52M
2021-03-31$17.44M$4.32M$17.41M(m)(m)-$12.92M
2020-09-30$15.35M$3.59M$13.90M(m)-$218.00K-$11.26M
2020-06-30$15.11M$3.68M$13.67M(m)(m)-$10.25M
2020-03-31$16.23M$4.16M$14.35M(m)(m)-$9.32M
2019-12-31$15.99M(m)(m)(m)(m)-$14.26M
2019-09-30$14.60M$7.10M$16.67M(m)$0.00-$10.37M
2019-06-30$15.00M$4.33M$16.61M(m)(m)-$12.39M
2019-03-31$17.45M$4.02M$25.67M(m)(m)-$14.88M
2018-12-31$16.03M(m)(m)(m)(m)-$9.75M
2018-09-30$4.47M$5.30M$19.39M(m)(m)-$24.17M
2018-06-30$3.89M$5.09M$21.73M(m)$240.00K-$22.68M
2018-03-31$3.46M$4.01M$20.62M(m)$0.00-$30.39M
2017-12-31$4.53M(m)(m)(m)(m)-$32.78M
2017-09-30$2.04M$4.58M$17.73M(m)$0.00-$32.89M
2017-06-30$2.16M$5.09M$18.57M(m)$0.00-$35.34M
2017-03-31$3.01M(m)$15.39M(m)$0.00-$16.32M
2016-12-31$12.40M(m)(m)(m)(m)$53.98M
2016-09-30$162.35M(m)$13.13M(m)$0.00$126.52M
2016-06-30$0.00(m)$11.11M(m)$0.00-$29.96M
2016-03-31$0.00(m)$7.35M$20.01M$0.00-$24.87M
2015-12-31$0.00*(m)(m)$272.86M*(m)-$277.02M
2015-09-30$0.00(m)$11.55M$26.00M$0.00-$31.86M
2015-06-30$0.00(m)$10.62M$24.05M$0.00-$28.91M
2015-03-31$0.00(m)(m)$21.74M$0.00-$30.66M
2014-12-31(m)(m)(m)(m)(m)-$36.44M
2014-09-30$0.00(m)(m)$38.27M$0.00-$36.52M
2014-06-30$0.00(m)(m)$69.85M$0.00-$73.36M
2014-03-31$0.00(m)(m)$41.41M$0.00-$52.06M
2013-12-31(m)(m)(m)(m)(m)-$53.58M
2013-09-30(m)(m)(m)$44.76M(m)-$50.82M
2013-06-30(m)(m)(m)$41.59M(m)-$46.12M
2013-03-31(m)(m)(m)$36.44M(m)-$40.97M
2012-12-31(m)(m)(m)(m)(m)-$51.78M
2012-09-30$35.00K(m)(m)$35.52M-$408.00K-$42.83M
2012-06-30(m)(m)(m)$44.05M(m)-$36.58M
2012-03-31(m)(m)(m)$33.93M(m)-$38.17M
2011-12-31(m)(m)(m)(m)(m)-$36.40M
2011-09-30(m)(m)(m)$32.77M(m)-$38.40M
2011-06-30(m)(m)(m)$39.19M(m)-$44.48M
2011-03-31$50.00K(m)(m)$38.05M(m)-$41.52M
2010-09-30(m)(m)(m)$42.54M(m)-$45.30M
2010-06-30$93.00K(m)(m)$37.36M(m)-$42.25M

Revenue and expense 6 month

Period endRevenueCost of revenueSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$199.54M$21.92M$112.39M$47.01M$147.00K-$35.65M
2025-06-30$154.88M$8.38M$56.64M$38.08M$731.00K$13.83M
2024-06-30$138.65M$9.42M$46.44M$38.98M$587.00K$8.62M
2023-06-30$89.24M$10.75M(m)$30.45M$0.00-$15.06M
2022-06-30$30.89M$6.90M$46.74M$23.91M$0.00-$55.02M
2021-06-30$40.72M$8.73M$37.47M$17.54M(m)-$48.44M
2020-06-30$31.35M$7.84M$28.02M(m)(m)-$19.57M
2019-06-30$32.45M$8.35M$42.28M(m)(m)-$27.27M
2018-06-30$7.36M$9.10M$42.35M(m)$240.00K-$53.06M
2017-06-30$5.17M$7.63M$33.96M(m)$0.00-$51.66M
2016-06-30$0.00(m)$18.46M(m)$0.00-$54.83M
2015-06-30$0.00(m)$21.10M$45.79M$0.00-$59.57M
2014-06-30$0.00(m)(m)$111.26M$0.00-$125.42M
2013-06-30(m)(m)(m)$78.02M(m)-$87.09M
2012-06-30(m)(m)(m)$77.99M(m)-$74.75M
2011-06-30$50.00K(m)(m)$77.24M(m)-$86.00M
2010-06-30$93.00K(m)(m)$77.96M(m)-$86.95M

Revenue and expense 9 month

Period endRevenueCost of revenueSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$237.01M$12.87M$85.72M(m)$527.00K$21.81M
2024-09-30$208.73M$12.62M$70.36M$57.00M$1.91M$20.17M
2023-09-30$140.49M$14.75M(m)$44.70M$0.00-$13.34M
2022-09-30$63.71M$11.92M$69.38M$41.37M$0.00-$69.45M
2021-09-30$62.93M$12.54M$54.69M$27.42M(m)-$52.87M
2020-09-30$46.70M$11.43M$41.92M(m)-$218.00K-$30.83M
2019-09-30$47.05M$15.45M$58.95M(m)$0.00-$37.64M
2018-09-30$11.83M$14.41M$61.74M(m)$240.00K-$77.22M
2017-09-30$7.21M$12.21M$51.68M(m)$0.00-$84.55M
2016-09-30$162.35M(m)$31.59M(m)$0.00$71.69M
2015-09-30$0.00(m)$32.65M$71.79M$0.00-$91.43M
2014-09-30$0.00(m)(m)$149.52M$0.00-$161.94M
2013-09-30(m)(m)(m)$122.78M(m)-$137.91M
2012-09-30$35.00K(m)(m)$113.51M-$408.00K-$117.58M
2011-09-30$50.00K(m)(m)$110.01M(m)-$124.41M
2010-09-30$93.00K(m)(m)$120.50M(m)-$132.25M

Revenue and expense 10 month

Period endNet income
1994-12-31-$2.00M

Revenue and expense 12 month

Period endRevenueCost of revenueSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$348.97M$26.80M$144.13M$87.96M-$4.46M$5.86M
2024-12-31$285.50M$17.43M$94.33M$76.60M$2.93M$27.59M
2023-12-31$198.96M$20.86M$94.31M$62.77M$1.56M-$11.94M
2022-12-31$99.77M$16.00M$91.47M$57.50M$0.00-$87.40M
2021-12-31$75.44M$16.83M$77.42M$38.86M$0.00-$80.93M
2020-12-31$65.14M$15.08M$59.04M$24.64M-$218.00K-$57.24M
2019-12-31$63.04M$20.08M$74.67M(m)$0.00-$51.90M
2018-12-31$27.86M$19.39M$79.72M(m)$240.00K-$86.97M
2017-12-31$11.74M$17.23M$74.96M(m)$51.00K-$117.33M
2016-12-31$174.76M$17.12M$46.93M(m)$0.00$125.66M
2015-12-31$0.00(m)$40.96M$344.65M$0.00-$368.44M
2014-12-31$0.00(m)$79.38M$179.63M$0.00-$198.38M
2013-12-31$0.00(m)(m)$169.40M$0.00-$191.49M
2012-12-31$35.00K(m)(m)$147.00M-$408.00K-$169.37M
2011-12-31$50.00K(m)(m)$140.59M(m)-$160.80M
2010-12-31$93.00K(m)(m)$152.59M(m)-$170.56M
2009-12-31(m)(m)(m)$209.78M(m)-$220.10M
2008-12-31(m)(m)(m)(m)(m)-$303.04M
2007-12-31(m)(m)(m)(m)(m)-$293.19M
2006-12-31(m)(m)(m)(m)(m)-$230.55M
2005-12-31(m)(m)(m)(m)(m)-$114.34M
2004-12-31(m)(m)(m)(m)(m)-$75.99M
2003-12-31(m)(m)(m)(m)(m)-$65.88M
2002-12-31(m)(m)(m)(m)(m)-$206.26M
2001-12-31(m)(m)(m)(m)(m)-$48.24M
2000-12-31(m)(m)(m)(m)(m)-$24.66M
1999-12-31(m)(m)(m)(m)(m)-$5.68M
1998-12-31(m)(m)(m)(m)(m)-$3.33M
1997-12-31(m)(m)(m)(m)(m)-$2.28M
1996-12-31(m)(m)(m)(m)(m)-$2.57M
1995-12-31(m)(m)(m)(m)(m)-$2.81M
1994-02-28(m)(m)(m)(m)(m)-$1.16M
1993-02-28(m)(m)(m)(m)(m)-$1.18M
1992-02-29(m)(m)(m)(m)(m)-$911.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19